Histogen to Report Second Quarter 2021 Financial Results on August 11, 2021

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO) has announced that its financial results for the second quarter will be released after the market closes on August 11, 2021. The company focuses on developing innovative restorative therapeutics aimed at promoting the body’s natural healing processes. Histogen’s technology utilizes cell-conditioned media and extracellular matrix materials, with applications in areas such as joint cartilage regeneration and hair growth.

Positive

• Potential for first-in-class restorative therapeutics.
• Innovative technology platform utilizing cell-conditioned media.

Negative

• None.

News Market Reaction – HSTO

+1.60%

+1.60% Session move

In the trading session that priced this news, HSTO gained 1.60%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Histogen’s financial results for the second quarter will be released after the close of market on Wednesday, August 11, 2021.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including joint cartilage regeneration, spinal disk repair, hair growth and dermal rejuvenation. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When will Histogen Inc. release its second quarter financial results?

Histogen Inc. will release its second quarter financial results after the market closes on August 11, 2021.

What is the focus of Histogen Inc.'s therapeutic development?

Histogen Inc. focuses on developing first-in-class restorative therapeutics that repair and maintain healthy biological function.

What technology does Histogen Inc. use in its products?

Histogen Inc. utilizes a technology platform that includes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells.

What are some applications of Histogen's technology?

Histogen's technology has applications in joint cartilage regeneration, spinal disk repair, hair growth, and dermal rejuvenation.